Factors Associated with the Development of Anemia After Subarachnoid Hemorrhage

作者: Tomoko R. Sampson , Rajat Dhar , Michael N. Diringer

DOI: 10.1007/S12028-009-9273-1

关键词: ErythropoiesisAnemiaIschemiaInternal medicineCardiologyVasospasmMedicineHemoglobinSystemic inflammatory response syndromeSurgerySubarachnoid hemorrhageBrain ischemia

摘要: Introduction Anemia is common after subarachnoid hemorrhage (SAH) and may exacerbate the reduction in oxygen delivery that underlies delayed cerebral ischemia. Fall hemoglobin relate to blood loss as well inflammatory suppression of erythropoiesis. Identifying factors associated with anemia facilitate targeted interventions, such use erythropoiesis-stimulating agents, which could minimize burden reduce red cell (RBC) transfusion requirements.

参考文章(29)
Cole A. Giller, Duke Samson, Angela M. Giller, Duke Samson, Distribution of Hematocrit Values After Aneurysmal Subarachnoid Hemorrhage Journal of Neuroimaging. ,vol. 8, pp. 169- 170 ,(1998) , 10.1111/JON199883169
William J. Powers, Robert L. Grubb, Roy P. Baker, Mark A. Mintun, Marcus E. Raichle, Regional cerebral blood flow and metabolism in reversible ischemia due to vasospasm. Determination by positron emission tomography. Journal of Neurosurgery. ,vol. 62, pp. 539- 546 ,(1985) , 10.3171/JNS.1985.62.4.0539
Matthew J. McGirt, Gustavo Pradilla, Federico G. Legnani, Quoc-Anh Thai, Pablo F. Recinos, Rafael J. Tamargo, Richard E. Clatterbuck, Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery. ,vol. 58, pp. 945- 951 ,(2006) , 10.1227/01.NEU.0000210262.67628.7E
Howard L. Corwin, Andrew Gettinger, Robert M. Rodriguez, Ronald G. Pearl, K. Dean Gubler, Christopher Enny, Theodore Colton, Michael J. Corwin, Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial Critical Care Medicine. ,vol. 27, pp. 2346- 2350 ,(1998) , 10.1097/00003246-199911000-00004
Howard L Corwin, Andrew Gettinger, Ronald G Pearl, Mitchell P Fink, Mitchell M Levy, Marc J Shapiro, Michael J Corwin, Theodore Colton, EPO Critical Care Trials Group, EPO Critical Care Trials Group, None, Efficacy of Recombinant Human Erythropoietin in Critically Ill Patients: A Randomized Controlled Trial JAMA. ,vol. 288, pp. 2827- 2835 ,(2002) , 10.1001/JAMA.288.22.2827
Ming-Yuan Tseng, Peter J. Hutchinson, Hugh K. Richards, Marek Czosnyka, John D. Pickard, Wendy N. Erber, Stephen Brown, Peter J. Kirkpatrick, Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article. Journal of Neurosurgery. ,vol. 111, pp. 171- 180 ,(2009) , 10.3171/2009.3.JNS081332
Paul E. Marik, Howard L. Corwin, Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Critical Care Medicine. ,vol. 36, pp. 2667- 2674 ,(2008) , 10.1097/CCM.0B013E3181844677
Silvana Naredi, Gavin Lambert, Peter Friberg, Stefan Zäll, Elisabeth Edén, Bertil Rydenhag, Maria Tylman, Anders Bengtsson, Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage. Intensive Care Medicine. ,vol. 32, pp. 1955- 1961 ,(2006) , 10.1007/S00134-006-0408-Y
Andrew M. Naidech, Borko Jovanovic, Katja E. Wartenberg, Augusto Parra, Noeleen Ostapkovich, E Sander Connolly, Stephan A. Mayer, Christopher Commichau, Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage* Critical Care Medicine. ,vol. 35, pp. 2383- 2389 ,(2007) , 10.1097/01.CCM.0000284516.17580.2C